| Not Yet Recruiting | Effect of a Novel Colonoscopic Lavage Solution on Colonoscopy Quality Colonoscopy | N/A | 2026-04-01 |
| Not Yet Recruiting | Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Dete Colonoscopy | N/A | 2026-04-01 |
| Not Yet Recruiting | A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squ Advanced Esophageal Squamous Cell Carcinoma | Phase 3 | 2026-04-01 |
| Not Yet Recruiting | The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function Stroke, Hemiplegia | N/A | 2026-03-01 |
| Not Yet Recruiting | IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer Advan'ce'd, Advanced | Phase 1 / Phase 2 | 2026-03-01 |
| Not Yet Recruiting | Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Sy Guillain-Barre Syndrome | N/A | 2026-01-01 |
| Not Yet Recruiting | Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumot Platinum-resistant Recurrent Ovarian Cancer (PROC) | Phase 2 | 2025-12-30 |
| Not Yet Recruiting | A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumo Esophageal Squamous Cell Carcinoma | Phase 2 | 2025-09-01 |
| Not Yet Recruiting | Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer Gastric Cancer | Phase 2 | 2025-08-15 |
| Recruiting | PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer Advanced Gastric Cancer, SHR1701 | Phase 2 | 2025-06-15 |
| Recruiting | Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC Non-Small Cell Lung Cancer, Chemotherapy, PD1 Antibody | Phase 1 | 2025-06-01 |
| Active Not Recruiting | Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network Lung Diseases, Endocrine Diseases, Gastrointestinal Diseases | — | 2025-06-01 |
| Not Yet Recruiting | NR vs. Vitamin E in Enhancing Fertility Infertility Female | N/A | 2025-05-05 |
| Recruiting | Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occ Chronic Total Occlusions of Coronary Arteries, Chronic Total Occlusion (CTO), Coronary Artery Disease (CAD) | N/A | 2025-04-28 |
| Recruiting | A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Acute Lymphoblastic Leukemia, Pediatric | Phase 2 | 2025-03-17 |
| Recruiting | Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer Female, Age ≥ 18 Years Old, No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy, ECOG Score of 0-1 | Phase 2 | 2025-03-10 |
| Recruiting | A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI C Acute Lymphoblastic Leukemia, Pediatric | Phase 2 | 2025-03-01 |
| Recruiting | A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI C Acute Lymphoblastic Leukemia, Adult | Phase 2 | 2025-03-01 |
| Recruiting | A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Acute Lymphoblastic Leukemia, Adult | Phase 2 | 2025-03-01 |
| Not Yet Recruiting | Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer Locally Advanced Rectal Cancer | Phase 2 | 2025-01-20 |
| Not Yet Recruiting | Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcin Esophageal Squamous Cell Carcinoma (ESCC) | Phase 1 / Phase 2 | 2025-01-01 |
| Recruiting | A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurren HCC | Phase 4 | 2024-12-04 |
| Enrolling By Invitation | Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cance Gallbladder Cancer and Extrahepatic Cholangiocarcinoma | Phase 2 | 2024-11-08 |
| Recruiting | Energy CT in Imaging and Diagnosis of Gastric Cancer Gastric Cancer, CT | — | 2024-09-01 |
| Recruiting | Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer Esophageal Squamous Cell Carcinoma | Phase 2 | 2024-08-15 |
| Enrolling By Invitation | Effects of ITBS Combined with NMES on Dysphagia After Stroke Stroke, Dysphagia, Intermittent Theta Burst Stimulation | N/A | 2024-08-03 |
| Not Yet Recruiting | Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC HER2-positive Gastric Cancer | Phase 2 | 2024-07-15 |
| Not Yet Recruiting | RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer HER2-positive Gastric Cancer | Phase 2 | 2024-07-06 |
| Completed | Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer Thyroid Cancer | Phase 4 | 2024-07-01 |
| Recruiting | Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project. Chronic Hepatitis b | — | 2024-06-03 |
| Completed | Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Urologic Cancer, Prostate, Robot Assisted Laparoscopic Radical Prostatectomy | N/A | 2024-05-16 |
| Recruiting | Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC) Cancer, Brain Injury | — | 2024-03-01 |
| Recruiting | Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain Brain Glioma | N/A | 2024-03-01 |
| Unknown | Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 2 | 2024-01-31 |
| Unknown | Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Metastatic Colorectal Cancer | Phase 2 | 2024-01-19 |
| Unknown | Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage Gastric Cancer | — | 2024-01-11 |
| Completed | Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node Metastas Thyroid Cancer | — | 2024-01-01 |
| Recruiting | Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Acute Ischemic Stroke | — | 2023-12-30 |
| Completed | The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19 COVID-19, Azvudine | — | 2023-12-05 |
| Unknown | IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC) Esophageal Squamous Cell Carcinoma (ESCC), PD-1 Inhibitors | Phase 2 | 2023-10-01 |
| Not Yet Recruiting | Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (E Esophageal Squamous Cell Carcinoma | Phase 2 | 2023-08-01 |
| Not Yet Recruiting | Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III C MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin | Phase 2 | 2023-06-01 |
| Unknown | Cortical Function Changes During Swallowing in Patients With Dysphagia in Lateral Medullary Syndrome Deglutition Disorders, Lateral Medullary Syndrome | — | 2023-05-31 |
| Unknown | Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Advanced Biliary Tract Cancer | Phase 2 | 2023-04-10 |
| Recruiting | Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma Esophageal Cancer | Phase 2 | 2023-03-08 |
| Recruiting | Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC Esophageal Cancer by AJCC V8 Stage | Phase 2 | 2023-03-02 |
| Unknown | Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade Esophageal Squamous Cell Carcinoma | Phase 2 | 2022-12-01 |
| Recruiting | Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction Brain Stem Infarctions, Dysphagia, Oropharyngeal, Dysphagia, Esophageal | N/A | 2022-11-11 |
| Recruiting | Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Cricopharyngeal Achalasia, Dysphagia | N/A | 2022-11-01 |
| Unknown | A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion Malignant Pleural Effusion | Phase 1 / Phase 2 | 2022-08-01 |
| Unknown | Mindfulness Yoga and Sexual Functioning Breast Cancer, Sexual Dysfunction | N/A | 2022-08-01 |
| Unknown | An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metast Breast Cancer, Breast Cancer Female | Phase 2 | 2022-07-01 |
| Recruiting | MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC NSCLC | Phase 2 | 2022-06-20 |
| Not Yet Recruiting | Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advance HER2-positive or Mutated Advanced Colorectal Cancer | Phase 2 | 2022-06-20 |
| Not Yet Recruiting | Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First- Advanced Colorectal Cancer | Phase 2 | 2022-06-15 |
| Unknown | Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Adva Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | 2022-06-01 |
| Unknown | A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia Tumor Therapy-related Thrombocytopenia | Phase 2 | 2022-06-01 |
| Unknown | Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gast Metastatic Gastric Cancer | Phase 1 / Phase 2 | 2022-06-01 |
| Unknown | A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-posit Gastric Cancer | Phase 2 | 2022-05-07 |
| Unknown | Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer Esophageal Neoplasms | — | 2022-05-05 |
| Completed | Genetic Research on High Myopic Individuals in Northern China High Myopia | — | 2022-05-01 |
| Unknown | Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the Head and Neck Squamous Cell Carcinoma | Phase 2 | 2022-03-30 |
| Unknown | Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcin Esophageal Squamous Cell Carcinoma | Phase 2 | 2022-03-14 |
| Unknown | AK105 Combined With Anlotinib in Patients With Cervical Cancer Cervical Cancer | Phase 2 | 2022-03-01 |
| Not Yet Recruiting | A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dM Colon Cancer | Phase 2 | 2022-03-01 |
| Recruiting | A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC Esophageal Cancer | Phase 2 | 2022-01-15 |
| Unknown | Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer Esophageal Cancer | N/A | 2022-01-01 |
| Unknown | Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-12-31 |
| Unknown | Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC Stomach Cancer | Phase 2 | 2021-12-01 |
| Completed | Tislelizumab in Addition to BACE in Patients with NSCLC NSCLC | Phase 2 | 2021-12-01 |
| Unknown | Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-12-01 |
| Unknown | A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-12-01 |
| Unknown | A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcino Resectable Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-10-01 |
| Unknown | Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Ca Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-09-01 |
| Unknown | Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B Chronic Hepatitis B, Mother-to-Child Transmission, Safety | Phase 4 | 2021-04-26 |
| Completed | Thrombolysis of Urokinase for Minor Stroke Minor Stroke | Phase 3 | 2020-10-04 |
| Completed | A Clinical Study on Ozone Autohemotherapy for the Treatment of Acute Ischemic Stroke Acute Ischemic Cerebrovascular Disease | N/A | 2020-08-01 |
| Unknown | Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC HCC | Phase 3 | 2020-05-01 |
| Unknown | The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | 2020-04-07 |
| Recruiting | A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Sq Esophageal Cancer | Phase 2 | 2019-12-05 |
| Unknown | A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiothera Esophageal Squamous Cell Carcinoma | Phase 2 | 2019-10-01 |
| Unknown | Novel Treatment of Advanced Hepatocellular Carcinoma HCC | Phase 3 | 2019-04-10 |
| Unknown | Treatment of Advanced Intrahepatic Cholangiocarcinoma ICC | Phase 3 | 2019-02-01 |
| Unknown | Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma | Phase 2 | 2019-01-13 |
| Unknown | Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis Glioma | — | 2018-11-01 |
| Unknown | Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis Vertebral Artery Stenosis | Phase 2 | 2018-05-03 |
| Unknown | A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma | Phase 2 | 2018-02-07 |
| Unknown | Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI ST Segment Elevation Myocardial Infarction, Elective Percutaneous Coronary Intervention | N/A | 2018-01-08 |
| Unknown | Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI ST Segment Elevation Myocardial Infarction, Primary Percutaneous Coronary Intervention | N/A | 2018-01-07 |
| Completed | The Effect of Vitamin D on in Vitro Fertilization Outcome Ongoing Pregnancy Rate, Vitamin D, In Vitro Fertilization | — | 2018-01-01 |
| Unknown | Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas Recurrent Glioma | — | 2018-01-01 |
| Unknown | Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas Glioma, Molecular Sequence Variation, Genetic Change | — | 2018-01-01 |
| Unknown | Botulinum Toxin for Trigeminal Neuralgia Trigeminal Neuralgia | Phase 3 | 2017-11-07 |
| Completed | Site Selection of Short Peripheral Venous Catheters Short Peripheral Venous Catheter | N/A | 2017-09-29 |
| Unknown | Treatment of Advanced Hepatocellular Carcinoma HCC | Phase 3 | 2017-07-18 |
| Unknown | Treatment of Intermediate-stage Hepatocellular Carcinoma HCC | Phase 3 | 2017-07-18 |
| Unknown | China Registry of Non-disabling Ischemic Cerebrovascular Events Transient Ischemic Attack, Minor Stroke | — | 2017-06-01 |
| Recruiting | Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence Glioma | — | 2017-01-01 |
| Recruiting | MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence Glioma | — | 2017-01-01 |
| Recruiting | Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence Glioma | — | 2017-01-01 |
| Recruiting | MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence Glioma | — | 2017-01-01 |
| Unknown | The Application of Time-lapse System in IVF/ICSI the Application of Time-lapes System in IVF/ICSI | — | 2016-11-01 |
| Unknown | Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma Advanced Esophageal Squamous Carcinoma | Phase 2 | 2016-10-01 |
| Completed | Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization Clinical Pregnancy Rate, Ovulation Induction, IVF | N/A | 2016-06-01 |
| Unknown | A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2016-05-01 |
| Unknown | Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embr Clinical Pregnancy Rate | N/A | 2016-01-01 |
| Unknown | the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation Critical Illness | Phase 4 | 2015-12-01 |
| Completed | Aminophylline for Patients With Post-Dural Puncture Headache Post-dural Puncture Headache | Phase 3 | 2015-10-01 |
| Unknown | The Effectiveness of Endometrial Injury in IVF Infertility | N/A | 2015-02-01 |
| Unknown | Effect of Endometrial Thickness on IVF Outcome Infertility | — | 2014-11-01 |
| Completed | In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency in Vitro Activation, Dormant Follicle, Primary Ovarian Insufficiency | — | 2014-09-01 |
| Recruiting | PCOS (Polycystic Ovarian Syndrome) Patients Health Related | — | 2010-01-01 |
| Recruiting | Newborns From Patients Treated With ART (Assisted Reproductive Technology) Health Related | — | 2010-01-01 |
| Recruiting | Azoospermia Patients Healthy Related | — | 2010-01-01 |
| Recruiting | Primary Ovarian Insufficient Patients Healthy Related | — | 2010-01-01 |